Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial

John M. Kirkwood; Michele Del Vecchio; Jeffrey Weber; Christoph Hoeller; Jean Jacques Grob; Peter Mohr; Carmen Loquai; Caroline Dutriaux; Vanna Chiarion-Sileni; Jacek Mackiewicz; Piotr Rutkowski; Petr Arenberger; Gaelle Quereux; Tarek M. Meniawy; Paolo A. Ascierto; Alexander M. Menzies; Piyush Durani; Maurice Lobo; Federico Campigotto; Brian Gastman; Georgina V. Long

doi:10.1038/s41591-023-02661-5

Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial

John M. Kirkwood, Michele Del Vecchio, Jeffrey Weber, Christoph Hoeller, Jean Jacques Grob, Peter Mohr, Carmen Loquai, Caroline Dutriaux, Vanna Chiarion-Sileni, Jacek Mackiewicz, Piotr Rutkowski, Petr Arenberger, Gaelle Quereux, Tarek M. Meniawy, Paolo A. Ascierto, Alexander M. Menzies, Piyush Durani, Maurice Lobo, Federico Campigotto, Brian GastmanGeorgina V. Long

Internal Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02583-2, published online 16 October 2023. In the version of the article initially published, John M. Kirkwood was presented in the author list without a middle initial. The error has been corrected in the HTML and PDF versions of the article.

Original language	English
Pages (from-to)	607
Number of pages	1
Journal	Nature Medicine
Volume	30
Issue number	2
DOIs	https://doi.org/10.1038/s41591-023-02661-5
Publication status	Published - Feb 2024

Access to Document

10.1038/s41591-023-02661-5

Cite this

Kirkwood, J. M., Del Vecchio, M., Weber, J., Hoeller, C., Grob, J. J., Mohr, P., Loquai, C., Dutriaux, C., Chiarion-Sileni, V., Mackiewicz, J., Rutkowski, P., Arenberger, P., Quereux, G., Meniawy, T. M., Ascierto, P. A., Menzies, A. M., Durani, P., Lobo, M., Campigotto, F., ... Long, G. V. (2024). Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial. Nature Medicine, 30(2), 607. https://doi.org/10.1038/s41591-023-02661-5

@article{a9902088866e42f28724c2bb3718b675,

title = "Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial",

abstract = "Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02583-2, published online 16 October 2023. In the version of the article initially published, John M. Kirkwood was presented in the author list without a middle initial. The error has been corrected in the HTML and PDF versions of the article.",

author = "Kirkwood, {John M.} and {Del Vecchio}, Michele and Jeffrey Weber and Christoph Hoeller and Grob, {Jean Jacques} and Peter Mohr and Carmen Loquai and Caroline Dutriaux and Vanna Chiarion-Sileni and Jacek Mackiewicz and Piotr Rutkowski and Petr Arenberger and Gaelle Quereux and Meniawy, {Tarek M.} and Ascierto, {Paolo A.} and Menzies, {Alexander M.} and Piyush Durani and Maurice Lobo and Federico Campigotto and Brian Gastman and Long, {Georgina V.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2023.",

year = "2024",

month = feb,

doi = "10.1038/s41591-023-02661-5",

language = "English",

volume = "30",

pages = "607",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group - Macmillan Publishers",

number = "2",

}

Kirkwood, JM, Del Vecchio, M, Weber, J, Hoeller, C, Grob, JJ, Mohr, P, Loquai, C, Dutriaux, C, Chiarion-Sileni, V, Mackiewicz, J, Rutkowski, P, Arenberger, P, Quereux, G, Meniawy, TM, Ascierto, PA, Menzies, AM, Durani, P, Lobo, M, Campigotto, F, Gastman, B & Long, GV 2024, 'Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial', Nature Medicine, vol. 30, no. 2, pp. 607. https://doi.org/10.1038/s41591-023-02661-5

TY - JOUR

T1 - Publisher Correction

T2 - Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial

AU - Kirkwood, John M.

AU - Del Vecchio, Michele

AU - Weber, Jeffrey

AU - Hoeller, Christoph

AU - Grob, Jean Jacques

AU - Mohr, Peter

AU - Loquai, Carmen

AU - Dutriaux, Caroline

AU - Chiarion-Sileni, Vanna

AU - Mackiewicz, Jacek

AU - Rutkowski, Piotr

AU - Arenberger, Petr

AU - Quereux, Gaelle

AU - Meniawy, Tarek M.

AU - Ascierto, Paolo A.

AU - Menzies, Alexander M.

AU - Durani, Piyush

AU - Lobo, Maurice

AU - Campigotto, Federico

AU - Gastman, Brian

AU - Long, Georgina V.

PY - 2024/2

Y1 - 2024/2

N2 - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02583-2, published online 16 October 2023. In the version of the article initially published, John M. Kirkwood was presented in the author list without a middle initial. The error has been corrected in the HTML and PDF versions of the article.

AB - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02583-2, published online 16 October 2023. In the version of the article initially published, John M. Kirkwood was presented in the author list without a middle initial. The error has been corrected in the HTML and PDF versions of the article.

UR - http://www.scopus.com/inward/record.url?scp=85175607189&partnerID=8YFLogxK

U2 - 10.1038/s41591-023-02661-5

DO - 10.1038/s41591-023-02661-5

M3 - Comment/debate

C2 - 37923838

AN - SCOPUS:85175607189

SN - 1078-8956

VL - 30

SP - 607

JO - Nature Medicine

JF - Nature Medicine

IS - 2

ER -

Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial

Abstract

Access to Document

Other files and links

Fingerprint

Cite this